Details of the Drug

General Information of Drug (ID: DMV2G7K)

Drug Name

Talineuren

Indication

Disease Entry	ICD 11	Status	REF
Parkinson disease	8A00.0	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04976127) Safety Evaluation of Intravenous Talineuren (TLN) in Parkinson's Disease-affected Patients. U.S.National Institutes of Health.